The portable device uses HeartBeam's patented 3D vectorelectrocardiography (3D VECG) technology to capture signals from three different projections and deliver a synthetic 12-lead ECG.

When Boston Scientific’s coronary DCB gained approval in the United States, it was a moment the country's cardiologists had been looking forward to for years. The cardiologists who researched the device have now detailed their findings, highlighting the "unmet need" this technology is addressing. 

Just 10.5% of U.S. physicians said they view private equity ownership in healthcare in a positive light. 

The Heart Failure Society of America shared a new scientific statement about this topic, noting that many patients may require additional help.

The shields can significantly reduce radiation exposure, according to cardiologist David G. Rizik, MD. He said they also allow cardiologists, nurses and other cath lab employees to provide care without wearing lead aprons. 

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Diet sodas made with artificial sweeteners are associated with an even higher risk of issues than sugar-sweetened sodas.

The FDA-approved technology developed by HeartFlow can predict a patient's long-term risk of target vessel failure as well as more invasive treatments performed inside a cath lab. 

Two new studies evaluated the long-term impact of choosing TAVR when low-risk patients present with severe aortic stenosis. 

Leslee J. Shaw, PhD, and Martha Gulati, MD, are joining forces to discuss how CAD presents in women, advances in imaging technology and much more.